Development
After selecting molecules with soon-to-expire patents and enough generic-penetration potential, we aim to receive marketing authorizations as first generics by working closely with our partners in dossier development, clinical trials, and toll manufacturing.
Manufacturing
Depending on the dosage form and manufacturing process involved, we would carefully select toll manufacturers that are technically qualified, pocess strong record of adherence to GMP, and have capacity for potential future scale-up.
Market Expansion
We would first target customers that are more price-senstitive, before listing in tenders of public and private hospitals. Market expansion leads to economies of scale and drives down the unit production cost, which help preserve lasting competitiveness.
